Tang Capital Management as of June 30, 2014
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 12 positions in its portfolio as reported in the June 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Heron Therapeutics (HRTX) | 28.1 | $61M | 4.9M | 12.32 | |
| Pdl Biopharma Inc cnv | 22.1 | $48M | 26M | 1.84 | |
| Salix Pharmaceuticals | 17.1 | $37M | 300k | 123.35 | |
| OPK CB 3 01FEB2033 144A BOND 01feb2033 | 8.7 | $19M | 14M | 1.34 | |
| D Horizon Pharma | 7.3 | $16M | 1.0M | 15.82 | |
| BioMarin Pharmaceutical (BMRN) | 5.2 | $11M | 182k | 62.21 | |
| La Jolla Pharmaceuticl Com Par | 3.8 | $8.1M | 882k | 9.18 | |
| Merrimack Pharmaceuticals In note 4.500% 7/1 | 3.5 | $7.5M | 5.5M | 1.36 | |
| Mirati Therapeutics | 2.7 | $5.8M | 288k | 20.00 | |
| Endocyte | 1.4 | $3.1M | 466k | 6.59 | |
| Dendreon Corporation | 0.1 | $128k | 56k | 2.30 | |
| Ambit Bioscience | 0.0 | $0 | 46.00 | 0.00 |
